SOMALOGIC INC (SLGC) Fundamental Analysis & Valuation
NASDAQ:SLGC • US83444K1051
Current stock price
2.1 USD
-0.1 (-4.55%)
At close:
2 USD
-0.1 (-4.76%)
After Hours:
This SLGC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SLGC Profitability Analysis
1.1 Basic Checks
- In the past year SLGC has reported negative net income.
- SLGC had a negative operating cash flow in the past year.
1.2 Ratios
- SLGC has a Return On Assets of -23.08%. This is in the lower half of the industry: SLGC underperforms 68.85% of its industry peers.
- SLGC has a Return On Equity (-26.25%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -23.08% | ||
| ROE | -26.25% | ||
| ROIC | N/A |
ROA(3y)-17.05%
ROA(5y)N/A
ROE(3y)-20.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- SLGC has a Gross Margin of 41.14%. This is comparable to the rest of the industry: SLGC outperforms 44.26% of its industry peers.
- SLGC's Gross Margin has improved in the last couple of years.
- The Profit Margin and Operating Margin are not available for SLGC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.14% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.12%
GM growth 5YN/A
2. SLGC Health Analysis
2.1 Basic Checks
- SLGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for SLGC has been increased compared to 1 year ago.
- SLGC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 2.03 indicates that SLGC is not a great score, but indicates only limited risk for bankruptcy at the moment.
- SLGC has a Altman-Z score (2.03) which is comparable to the rest of the industry.
- SLGC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.03 |
ROIC/WACCN/A
WACC12.33%
2.3 Liquidity
- A Current Ratio of 17.77 indicates that SLGC has no problem at all paying its short term obligations.
- SLGC has a better Current ratio (17.77) than 95.08% of its industry peers.
- SLGC has a Quick Ratio of 17.27. This indicates that SLGC is financially healthy and has no problem in meeting its short term obligations.
- SLGC has a better Quick ratio (17.27) than 95.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 17.77 | ||
| Quick Ratio | 17.27 |
3. SLGC Growth Analysis
3.1 Past
- The earnings per share for SLGC have decreased strongly by -50.00% in the last year.
- SLGC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.73%.
- The Revenue has been growing by 44.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)-19.73%
Revenue growth 3Y44.77%
Revenue growth 5YN/A
Sales Q2Q%-47.13%
3.2 Future
- Based on estimates for the next years, SLGC will show a small growth in Earnings Per Share. The EPS will grow by 3.80% on average per year.
- The Revenue is expected to grow by 11.84% on average over the next years. This is quite good.
EPS Next Y-2.43%
EPS Next 2Y3.89%
EPS Next 3Y4.51%
EPS Next 5Y3.8%
Revenue Next Year-12.14%
Revenue Next 2Y1.69%
Revenue Next 3Y7.5%
Revenue Next 5Y11.84%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. SLGC Valuation Analysis
4.1 Price/Earnings Ratio
- SLGC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SLGC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.89%
EPS Next 3Y4.51%
5. SLGC Dividend Analysis
5.1 Amount
- SLGC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SLGC Fundamentals: All Metrics, Ratios and Statistics
2.1
-0.1 (-4.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Industry Strength20.5
Industry Growth50.31
Earnings (Last)11-08 2023-11-08/amc
Earnings (Next)03-26 2024-03-26/amc
Inst Owners0.05%
Inst Owner Change0%
Ins Owners0.46%
Ins Owner Change0%
Market Cap396.23M
Revenue(TTM)81.73M
Net Income(TTM)-130.38M
Analysts80
Price Target4.01 (90.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.28%
Min EPS beat(2)17.77%
Max EPS beat(2)30.8%
EPS beat(4)3
Avg EPS beat(4)10.01%
Min EPS beat(4)-21.38%
Max EPS beat(4)30.8%
EPS beat(8)7
Avg EPS beat(8)20.72%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.4%
Min Revenue beat(2)1.23%
Max Revenue beat(2)5.58%
Revenue beat(4)4
Avg Revenue beat(4)7.3%
Min Revenue beat(4)1.23%
Max Revenue beat(4)11.55%
Revenue beat(8)6
Avg Revenue beat(8)11.99%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-21.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.46%
EPS NY rev (1m)0%
EPS NY rev (3m)11.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.85 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.8 | ||
| P/tB | 0.84 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.69
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS0.43
BVpS2.63
TBVpS2.49
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -23.08% | ||
| ROE | -26.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.14% | ||
| FCFM | N/A |
ROA(3y)-17.05%
ROA(5y)N/A
ROE(3y)-20.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.12%
GM growth 5YN/A
F-Score3
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 48.2% | ||
| Cap/Sales | 4.26% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 17.77 | ||
| Quick Ratio | 17.27 | ||
| Altman-Z | 2.03 |
F-Score3
WACC12.33%
ROIC/WACCN/A
Cap/Depr(3y)139.07%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.22%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y-2.43%
EPS Next 2Y3.89%
EPS Next 3Y4.51%
EPS Next 5Y3.8%
Revenue 1Y (TTM)-19.73%
Revenue growth 3Y44.77%
Revenue growth 5YN/A
Sales Q2Q%-47.13%
Revenue Next Year-12.14%
Revenue Next 2Y1.69%
Revenue Next 3Y7.5%
Revenue Next 5Y11.84%
EBIT growth 1Y-0.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.1%
EBIT Next 3Y14.46%
EBIT Next 5Y7.07%
FCF growth 1Y-359.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-444.14%
OCF growth 3YN/A
OCF growth 5YN/A
SOMALOGIC INC / SLGC Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for SOMALOGIC INC?
ChartMill assigns a fundamental rating of 3 / 10 to SLGC.
What is the valuation status of SOMALOGIC INC (SLGC) stock?
ChartMill assigns a valuation rating of 0 / 10 to SOMALOGIC INC (SLGC). This can be considered as Overvalued.
Can you provide the profitability details for SOMALOGIC INC?
SOMALOGIC INC (SLGC) has a profitability rating of 1 / 10.
Can you provide the financial health for SLGC stock?
The financial health rating of SOMALOGIC INC (SLGC) is 7 / 10.